Troikaa Pharmaceuticals is a finished-dose manufacturer based in India. It appears in 146 regulatory filings across 15 regulators, without an active US DMF or CEP on file. Its filings concentrate with ARCSA (EC), DAV (Vietnam) and ZAMRA (ZM). Its GMP standing is certified by CDSCO (India), UZPHARM (UZ) and NAFDAC (NG), among 6 authorities. Customs aggregates show $58.9M of exports covering 1,677 molecules to 77 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Dehradun, Colombia | Not on file |
| DEHRADUN, India | Not on file |
| Dehradun, India | Not on file |
| Ahmedabad, India | Not on file |
| tal sanandahmedabada hmedabad 382 170, India | Not on file |
| ahmedabad 382 110, India | Not on file |
2 further sites are on record.
| Regulator | Filings | GMP certificates |
|---|---|---|
| ARCSA (EC) | 26 | None |
| DAV (Vietnam) | 25 | None |
| ZAMRA (ZM) | 22 | None |
| MINSA (CR) | 17 | None |
| UZPHARM (UZ) | 14 | 3 |
| TMDA (TZ) | 11 | None |
| CDSCO (India) | None | 5 |
| NAFDAC (NG) | None | 3 |
| ANVISA (Brazil) | None | 2 |
| EMA | None | 1 |
| MCAZ (ZW) | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $13.5M | 44 |
| 2025 | Not reported | $58.9M | 77 |
| 2024 | Not reported | $48.3M | 68 |
| 2023 | Not reported | $48.6M | 71 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Troikaa Pharmaceuticals comes back tiered against every other supplier able to file there.
Start for free